• 1
    Haider MA, Amoozadeh Y, Jhaveri KS. DW-MRI for disease characterization in the pelvis. In Koh DM, Thoeny HC eds, Diffusion-Weighted MR Imaging: Applications in the Body, Chapt 9. Berlin: Springer-Verlag, 2010: 14356
  • 2
    Zelhof B, Pickles M, Liney G et al. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 2009; 103: 8838
  • 3
    Yoshimitsu K, Kiyoshima K, Irie H et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008; 27: 1329
  • 4
    Rosenkrantz AB, Kopec M, Kong X et al. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging 2010; 31: 138794
  • 5
    Park BK, Lee HM, Kim CK, Choi HY, Park JW. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol 2008; 43: 78993
  • 6
    Portalez D, Rollin G, Leandri P et al. Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol 2010; 20: 278190
  • 7
    deSouza NM, Riches SF, Vanas NJ et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008; 63: 77482
  • 8
    van As NJ, de Souza NM, Riches SF et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. Eur Urol 2009; 56: 9817
  • 9
    Park SY, Kim CK, Park BK, Lee HM, Lee KS. Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results. Eur Radiol 2011; 21: 11118
  • 10
    Ren J, Huan Y, Wang H et al. Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 2009; 19: 24816
  • 11
    Ren J, Huan Y, Li F et al. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma. J Magn Reson Imaging 2009; 30: 3516
  • 12
    Mir N, Sohaib SA, Collins D, Koh DM. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol 2010; 54: 35864
  • 13
    Eiber M, Beer AJ, Holzapfel K et al. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 2010; 45: 1523
  • 14
    Luboldt W, Kufer R, Blumstein N et al. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 2008; 249: 101725
  • 15
    Gutzeit A, Doert A, Froehlich JM et al. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 2010; 39: 33343
  • 16
    Song I, Kim CK, Park BK, Park W. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. AJR Am J Roentgenol 2010; 194: W47782
  • 17
    Kim CK, Park BK, Lee HM. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 2009; 29: 3917
  • 18
    Kim CK, Park BK, Lee HM, Kim SS, Kim E. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 2008; 190: 11806
  • 19
    Reischauer C, Froehlich JM, Koh DM et al. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps – initial observations. Radiology 2010; 257: 52331
  • 20
    Gurses B, Tasdelen N, Yencilek F et al. Diagnostic utility of DTI in prostate cancer. Eur J Radiol 2010; [Epub ahead of print]